398 related articles for article (PubMed ID: 21497648)
1. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways.
Wang X; Wang Y; Jiang M; Zhu Y; Hu L; Fan G; Wang Y; Li X; Gao X
J Ethnopharmacol; 2011 Jun; 135(3):662-71. PubMed ID: 21497648
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells.
Jia LQ; Yang GL; Ren L; Chen WN; Feng JY; Cao Y; Zhang L; Li XT; Lei P
J Ethnopharmacol; 2012 Aug; 143(1):100-8. PubMed ID: 22750433
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury.
Pan H; Li D; Fang F; Chen D; Qi L; Zhang R; Xu T; Sun H
J Cardiovasc Pharmacol; 2011 Nov; 58(5):535-42. PubMed ID: 21795988
[TBL] [Abstract][Full Text] [Related]
6. Cerebral protection of salvianolic acid A by the inhibition of granulocyte adherence.
Jiang M; Wang XY; Zhou WY; Li J; Wang J; Guo LP
Am J Chin Med; 2011; 39(1):111-20. PubMed ID: 21213402
[TBL] [Abstract][Full Text] [Related]
7. Proteomic studies on protective effects of salvianolic acids, notoginsengnosides and combination of salvianolic acids and notoginsengnosides against cardiac ischemic-reperfusion injury.
Yue QX; Xie FB; Song XY; Wu WY; Jiang BH; Guan SH; Yang M; Liu X; Guo DA
J Ethnopharmacol; 2012 Jun; 141(2):659-67. PubMed ID: 21903157
[TBL] [Abstract][Full Text] [Related]
8. Danshen-Gegen decoction exerts proliferative effect on rat cardiac myoblasts H9c2 via MAPK and insulin pathways.
Fong CC; Wei F; Chen Y; Yu WK; Koon CM; Leung PC; Fung KP; Lau CB; Yang M
J Ethnopharmacol; 2011 Oct; 138(1):60-6. PubMed ID: 21907783
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Tanshinone IIA, salvianolic acid A and salvianolic acid B on Areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Zhu DX; Sheng JT; Chen XX; Li WZ; Wang GF; Li KS; Su Y
Molecules; 2015 Apr; 20(4):6794-807. PubMed ID: 25884554
[TBL] [Abstract][Full Text] [Related]
11. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
[TBL] [Abstract][Full Text] [Related]
12. [Study on regulation of tanshinone II(A) on GFAP and ATPase and PDI of cerebral ischemia reperfusion injury in rats].
Wen PY; Yang FZ; Wang F; Li WW; Zhou L; Huang LH; Zhou J
Zhong Yao Cai; 2012 Oct; 35(10):1628-32. PubMed ID: 23627131
[TBL] [Abstract][Full Text] [Related]
13. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
Ren-an Q; Juan L; Chuyuan L; Wenjuan F; Chunyan H; Xuemei Y; Lin H; Hong N
J Ethnopharmacol; 2014 Oct; 156():190-8. PubMed ID: 25178948
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling analysis of HMP-treated rats with experimentally induced myocardial infarction.
Fan X; Shi M; Wang Y; Liang Q; Luo G
J Ethnopharmacol; 2011 Sep; 137(1):199-204. PubMed ID: 21605651
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats.
Wang SB; Tian S; Yang F; Yang HG; Yang XY; Du GH
Eur J Pharmacol; 2009 Aug; 615(1-3):125-32. PubMed ID: 19445921
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats.
Xu W; Yang J; Wu LM
Pharmazie; 2009 May; 64(5):332-6. PubMed ID: 19530445
[TBL] [Abstract][Full Text] [Related]
17. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9.
Wang R; Zhang H; Wang Y; Yu X; Yuan Y
J Ethnopharmacol; 2016 Mar; 180():87-96. PubMed ID: 26806573
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes.
Zhou X; Wang Y; Or PM; Wan DC; Kwan YW; Yeung JH
Phytomedicine; 2012 May; 19(7):648-57. PubMed ID: 22541637
[TBL] [Abstract][Full Text] [Related]
19. Transformation of salvianolic acid B to salvianolic acid a in aqueous solution and the in vitro liver protective effect of the main products.
Kan S; Chen Z; Shao L; Li J
J Food Sci; 2014 Apr; 79(4):C499-504. PubMed ID: 24689808
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice.
Du G; Zhang J
Chin Med J (Engl); 1997 Jan; 110(1):65-8. PubMed ID: 9594327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
